RT Book, Section A1 Havrda, Dawn A2 Linn, William D. SR Print(0) ID 1190596903 T1 The Effect of a New GLP-1 Agonist, Efpeglenatide, on Cardiovascular and Renal Outcomes in Diabetes T2 Topics in Evidence-Based Pharmacy Practice YR 2016 FD 2016 PB McGraw Hill PP New York, NY SN LK accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=582750 RD 2024/03/29 AB